Dirk M. Nettelbeck

4.3k total citations
83 papers, 3.4k citations indexed

About

Dirk M. Nettelbeck is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Dirk M. Nettelbeck has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Genetics, 61 papers in Molecular Biology and 45 papers in Oncology. Recurrent topics in Dirk M. Nettelbeck's work include Virus-based gene therapy research (63 papers), CAR-T cell therapy research (40 papers) and Viral Infectious Diseases and Gene Expression in Insects (32 papers). Dirk M. Nettelbeck is often cited by papers focused on Virus-based gene therapy research (63 papers), CAR-T cell therapy research (40 papers) and Viral Infectious Diseases and Gene Expression in Insects (32 papers). Dirk M. Nettelbeck collaborates with scholars based in Germany, United States and France. Dirk M. Nettelbeck's co-authors include Rolf Müller, David T. Curiel, Valérie Jérôme, Johanna K. Kaufmann, Roland E. Kontermann, Ángel A. Rivera, Akseli Hemminki, Guy Ungerechts, Ronald D. Alvarez and Sascha Bossow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Dirk M. Nettelbeck

82 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk M. Nettelbeck Germany 36 2.2k 2.2k 1.6k 549 458 83 3.4k
Victor W. van Beusechem Netherlands 35 2.4k 1.1× 2.2k 1.0× 1.5k 0.9× 396 0.7× 362 0.8× 115 3.6k
Anna Kanerva Finland 39 2.5k 1.1× 3.8k 1.7× 3.1k 2.0× 695 1.3× 995 2.2× 125 4.7k
Ada Houweling Netherlands 20 1.8k 0.8× 1.8k 0.8× 959 0.6× 609 1.1× 150 0.3× 28 2.8k
Frederick J. Kohlhapp United States 14 919 0.4× 1.1k 0.5× 1.3k 0.8× 814 1.5× 260 0.6× 27 2.3k
Carol H. Miao United States 31 1.9k 0.9× 1.8k 0.8× 850 0.5× 405 0.7× 130 0.3× 83 3.4k
Galina Mikheeva United States 19 1.9k 0.9× 2.2k 1.0× 1.3k 0.8× 149 0.3× 277 0.6× 30 2.6k
Richard Mulligan United States 13 2.2k 1.0× 1.3k 0.6× 751 0.5× 791 1.4× 176 0.4× 14 3.2k
DT Curiel United States 26 1.5k 0.7× 1.4k 0.7× 713 0.5× 282 0.5× 218 0.5× 51 2.1k
Joe S. Mymryk Canada 38 2.8k 1.3× 1.8k 0.8× 1.3k 0.8× 732 1.3× 148 0.3× 152 4.3k
Karen Buchkovich United States 11 1.9k 0.9× 1.2k 0.5× 2.2k 1.4× 389 0.7× 203 0.4× 14 3.5k

Countries citing papers authored by Dirk M. Nettelbeck

Since Specialization
Citations

This map shows the geographic impact of Dirk M. Nettelbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk M. Nettelbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk M. Nettelbeck more than expected).

Fields of papers citing papers by Dirk M. Nettelbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk M. Nettelbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk M. Nettelbeck. The network helps show where Dirk M. Nettelbeck may publish in the future.

Co-authorship network of co-authors of Dirk M. Nettelbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk M. Nettelbeck. A scholar is included among the top collaborators of Dirk M. Nettelbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk M. Nettelbeck. Dirk M. Nettelbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Büning, Hildegard, Boris Fehse, Zoltán Ivics, et al.. (2021). Gene Therapy “Made in Germany”: A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy. Human Gene Therapy. 32(19-20). 987–996. 2 indexed citations
2.
Krackhardt, Angela M., Brigitte Anliker, Martin Hildebrandt, et al.. (2018). Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach. Cancer Immunology Immunotherapy. 67(4). 513–523. 12 indexed citations
3.
Ungerechts, Guy, Christine E. Engeland, Christian J. Buchholz, et al.. (2017). Virotherapy Research in Germany: From Engineering to Translation. Human Gene Therapy. 28(10). 800–819. 20 indexed citations
4.
Ketzer, Patrick, Johanna K. Kaufmann, Sascha Bossow, et al.. (2014). Artificial riboswitches for gene expression and replication control of DNA and RNA viruses. Proceedings of the National Academy of Sciences. 111(5). E554–62. 90 indexed citations
5.
Engeland, Christine E., Christian Grossardt, Rūta Veinalde, et al.. (2014). CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy. Molecular Therapy. 22(11). 1949–1959. 239 indexed citations
6.
Knippertz, Ilka, Jan Dörrie, Niels Schaft, et al.. (2011). Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. International Journal of Hyperthermia. 27(6). 591–603. 68 indexed citations
7.
Hesse, Andrea, Ilka Knippertz, Eckhart Kaempgen, et al.. (2011). Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature. International Journal of Cancer. 130(7). 1682–1694. 5 indexed citations
8.
Gorodetsky, Raphael, et al.. (2009). An in-vitro tumour microenvironment model using adhesion to type I collagen reveals Akt-dependent radiation resistance in renal cancer cells. Nephrology Dialysis Transplantation. 25(2). 373–380. 16 indexed citations
9.
Hesse, Andrea, Wibke Bayer, Christel Herold‐Mende, et al.. (2009). Transgene expression by oncolytic adenoviruses is modulated by E1B19K deletion in a cell type-dependent manner. Virology. 395(2). 243–254. 9 indexed citations
10.
Urieli-Shoval, Simcha, et al.. (2009). Human melanoma cells expressing the αvβ3 integrin are partially protected from necrotic cell death induced by dynamic matrix detachment. Cancer Letters. 290(2). 174–181. 4 indexed citations
11.
Nettelbeck, Dirk M., et al.. (2009). Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Advanced Drug Delivery Reviews. 61(7-8). 554–571. 121 indexed citations
12.
Avrahami, Idit, et al.. (2008). A novel dynamic matrix detachment model reveals a shift from apoptosis to necrosis in melanoma cells. Cancer Letters. 272(2). 345–354. 6 indexed citations
13.
Mainka, Astrid, et al.. (2007). Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells. International Journal of Cancer. 121(12). 2801–2807. 30 indexed citations
14.
Banerjee, N. Sanjib, Ángel A. Rivera, Minghui Wang, et al.. (2004). Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures. Molecular Cancer Therapeutics. 3(4). 437–449. 46 indexed citations
15.
Zhu, Zeng B., Sharmila Makhija, Baogen Lu, et al.. (2004). Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Cancer Gene Therapy. 11(4). 256–262. 86 indexed citations
16.
17.
Volk, Andrea L., Ángel A. Rivera, Anna Kanerva, et al.. (2003). Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism. Cancer Biology & Therapy. 2(5). 511–515. 59 indexed citations
18.
Nettelbeck, Dirk M., et al.. (2003). Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma. Melanoma Research. 13(3). 287–292. 19 indexed citations
19.
Brüsselbach, Sabine, et al.. (1998). Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cells. International Journal of Cancer. 77(1). 146–152. 81 indexed citations
20.
Nettelbeck, Dirk M., Valérie Jérôme, & Rolf Müller. (1998). A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Therapy. 5(12). 1656–1664. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor W. van Beusechem Breakdown of academic impact, for papers by Anna Kanerva Breakdown of academic impact, for papers by Ada Houweling Breakdown of academic impact, for papers by Frederick J. Kohlhapp Breakdown of academic impact, for papers by Carol H. Miao Breakdown of academic impact, for papers by Galina Mikheeva Breakdown of academic impact, for papers by Richard Mulligan Breakdown of academic impact, for papers by DT Curiel Breakdown of academic impact, for papers by Joe S. Mymryk Breakdown of academic impact, for papers by Karen Buchkovich
Rankless by CCL
2026